Pulmonary Hypertension in Cystic Fibrosis with Advanced Lung Disease
The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
Rationale: The impact of pulmonary hypertension (PH) on survival in cystic fibrosis (CF) remains unclear. Objectives: To determine the influence of PH on survival in the CF population. Methods: The United Network for Organ Sharing database was queried from 1987 to 2013 to identify first-time lung transplant candidates who were tracked from wait list entry date until death or censoring to determine influence of PH. Using right heart catheterization measurements, mild PH was defined as mean pulmonary artery pressure greater than or equal to 25 mm Hg and severe greater than or equal to 35 mm Hg. Measurements and Main Results: Of 2,781 CF patients, 2,100 were used for univariate analysis, 764 for Kaplan-Meier survival function, 687 for multivariate Cox models, and 576 and 132 for matching on the propensity of mild PH and severe PH, respectively. Univariate Cox analysis found significant differences in survival for mild PH (hazard ratio [HR], 1.747; 95% confidence interval [CI], 1.387–2.201; P < 0.001) and severe PH (HR, 2.299; 95% CI, 1.639–3.225; P < 0.001). Further assessment by multivariate Cox models identified significant risk for death associated with mild PH (HR, 1.757; 95% CI, 1.367–2.258; P < 0.001) and severe PH (HR, 2.284; 95% CI, 1.596–3.268; P < 0.001). Cox regression stratified on matched pairs of PH cases and control subjects confirmed the risk for death for mild PH (HR, 1.919; 95% CI, 1.290–2.85; P = 0.001) and severe PH (HR, 4.167; 95% CI, 1.709–10.157; P = 0.002). Conclusions: The manifestation of PH is associated with significantly increased risk for death in CF patients with advanced lung disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Additional risk factors for mortality in those with severely compromised lung function include FEV1< 25% predicted, rapid decline in FEV1, PaCO2 > 50mmHg, impaired functional status, and pulmonary hypertension. (244, 246–251)”
From Consensus document for the selection of lung transplant candidates: An update from the International Society for Heart and Lung Transplantation. (2021) · cites this paper as [250]
Citations
Cites
Updated Clinical Classification of Pulmonary Hypertension
Simonneau, G., Robbins, I. M., Beghetti, M., Channick, R. N., Delcroix, M., Denton, C. P., Elliott, C. G., Gaine, S. P., Gladwin, M. T., Jing, Z.-C., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.04.012 · Cited by 2,093
Echocardiographic Assessment of Pulmonary Hypertension in Patients with Advanced Lung Disease
Arcasoy, S. M., Christie, J. D., Ferrari, V. A., Sutton, M. S. J., Zisman, D. A., Blumenthal, N. P., Pochettino, A., & Kotloff, R. M. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200210-1130oc · Cited by 906 · cited 2×
“The need for a tricuspid regurgitation jet velocity with limited acoustic windows complicated by parenchymal lung disease can be associated with poor estimation of the hemodynamics of the pulmonary circulation (6, 25).”
Hoeper, M. M., Lee, S. H., Voswinckel, R., Palazzini, M., Jais, X., Marinelli, A., Barst, R. J., Ghofrani, H. A., Jing, Z.-C., Opitz, C., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.07.061 · Cited by 612
Prognostic value of pulmonary artery pressure in chronic obstructive pulmonary disease.
Weitzenblum, E., Hirth, C., Ducolone, A., Mirhom, R., Rasaholinjanahary, J., & Ehrhart, M. (1981) · Thorax · doi:10.1136/thx.36.10.752 · Cited by 488 · cited 1×
“These cutoff parameters were chosen arbitrarily because there are no published severity guidelines for PH caused by hypoxemia and lung disease with previous reports (1, 23) describing 25–35 mm Hg as modest PH.”
The Influence of Hydrogen Ion Concentration and Hypoxia on the Pulmonary Circulation*
Enson, Y., Giuntini, C., Lewis, M. L., Morris, T. Q., Ferrer, M. I., & Harvey, R. M. (1964) · Journal of Clinical Investigation · doi:10.1172/jci104999 · Cited by 268 · cited 1×
“The pathophysiology of PH in lung disease in general, including CF, involves alveolar hypoxemia (26), acidosis (26), and hypercapnia (3) playing important roles.”
Risk factors for death of patients with cystic fibrosis awaiting lung transplantation
Belkin, R. A., Henig, N. R., Singer, L. G., Chaparro, C., Rubenstein, R. C., Xie, S. X., Yee, J. Y., Kotloff, R. M., Lipson, D. A., & Bunin, G. R. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200410-1369oc · Cited by 180
Arterial stiffness: clinical relevance, measurement and treatment
Hamilton, P. K., Lockhart, C. J., Quinn, C. E., & Mcveigh, G. E. (2007) · Clinical Science · doi:10.1042/cs20070080 · Cited by 174 · cited 1×
“Using a validated technique to evaluate arterial wall integrity (35) in a cross-sectional study involving 50 adult CF patients, Hull and coworkers (33) found that arterial stiffness was significantly increased in the presence of a normal blood pressure and independent of diabetic status, while being associated with sy…”
Peacock, A. J., Crawley, S. F., McLure, L. E. R., Blyth, K. G., Vizza, C. D., Poscia, R., Francone, M., Iacucci, I., Olschewski, H., Kovács, G., et al. (2013) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.113.000629 · Cited by 172
Pulmonary Hypertension and Cardiac Function in Adult Cystic Fibrosis
Fraser, K. L., Tullis, D. E., Sasson, Z., Hyland, R. H., Thornley, K. S., & Hanly, P. J. (1999) · Chest · doi:10.1378/chest.115.5.1321 · Cited by 161
Pulmonary hypertension and cor pulmonale in cystic fibrosis of the pancreas
Goldring, R. M., Fishman, A. P., Turino, G. M., Cohen, H. I., Denning, C. R., & Andersen, D. H. (1964) · The Journal of Pediatrics · doi:10.1016/s0022-3476(64)80286-9 · Cited by 119
Brecker, S. J., Gibbs, J. S., Fox, K. M., Yacoub, M. H., & Gibson, D. G. (1994) · Heart · doi:10.1136/hrt.72.4.384 · Cited by 99 · cited 1×
“However, this diagnostic technology requires estimates of tricuspid regurgitation jet velocity and is associated with underestimation of pressures in patients with high PAP and overestimation of PAP in patients without significant elevation (24, 25).”
Swift, A. J., Wild, J. M., Nagle, S. K., Roldán‐Alzate, A., François, C. J., Fain, S. B., Johnson, K. R., Capener, D. A., van Beek, E. J. R., Kiely, D. G., et al. (2014) · Journal of Thoracic Imaging · doi:10.1097/rti.0000000000000079 · Cited by 95
IONESCU, A. A., IONESCU, A.-A., PAYNE, N., OBIETA-FRESNEDO, I., FRASER, A. G., & SHALE, D. J. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.163.5.9908005 · Cited by 87 · cited 2×
“Until the time for referral for LTx, transthoracic echocardiography is commonly used as a surrogate to assess right ventricular function and look for PH in CF, but it is limited (6, 10).”
Stern, R. C. (1980) · American journal of diseases of children · doi:10.1001/archpedi.1980.02130150025007 · Cited by 84
Evidence of Vascular Endothelial Dysfunction in Young Patients With Cystic Fibrosis
Poore, T. S., Berry, B., Eidson, D., McKie, K. T., & Harris, R. A. (2013) · CHEST Journal · doi:10.1378/chest.12-1934 · Cited by 84 · cited 1×
“Recently, endothelial dysfunction was reported in young, healthy CF patients compared with matched control subjects (32).”
Right Ventricular Dysfunction in Adult Severe Cystic Fibrosis
Florea, V. G., Florea, N. D., Sharma, R., Coats, A. J. S., Gibson, D. G., Hodson, M. E., & Henein, M. Y. (2000) · CHEST Journal · doi:10.1378/chest.118.4.1063 · Cited by 83
Increased augmentation index in patients with cystic fibrosis
Hull, J. H., Garrod, R., Ho, T. B. L., Knight, R. K., Cockcroft, J. R., Shale, D. J., & Bolton, C. E. (2009) · European Respiratory Journal · doi:10.1183/09031936.00044009 · Cited by 67 · cited 2×
“Important limitations of the study by Hull and coworkers (33) were the exclusion of confounders including hypoxemia, hypoventilation, and post-transplant patients.”
Fauroux, B., Pépin, J., Boëlle, P., Cracowski, C., Murris‐Espin, M., NOVE-JOSSERAND, R., Stremler, N., Simon, T., & Burgel, P. (2012) · Archives of Disease in Childhood · doi:10.1136/archdischild-2011-300440 · Cited by 67
Sex differences in the pulmonary circulation: implications for pulmonary hypertension
Martin, Y. N., & Pabelick, C. M. (2014) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00857.2013 · Cited by 65 · cited 1×
“Unlike other patient groups with PH where females are more commonly afflicted while males have worse outcomes (36), the present study found no significant difference in prevalence and survival outcomes regarding sex and PH in the CF population.”
Prevalence of pulmonary hypertension in end-stage cystic fibrosis and correlation with survival
Tonelli, A. R., Fernández-Bussy, S., Lodhi, S., Akindipe, O., Carrie, R. D., Hamilton, K. K., Mubarak, K. K., & Baz, M. A. (2010) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2010.04.006 · Cited by 50
Endothelial Activation and Increased Heparan Sulfate Expression in Cystic Fibrosis
Solic, N., Wilson, J. W., Wilson, S. J., & Shute, J. K. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200409-1207oc · Cited by 49 · cited 1×
“Although not well-defined, chronic systemic inflammation plays a role with associated alterations of the endothelium (29–34) with differences reported between CF and other lung diseases (31).”
CFTR Regulation of Intracellular pH and Ceramides Is Required for Lung Endothelial Cell Apoptosis
Noe, J. E., Petrusca, D. N., Rush, N. I., Deng, P., VanDemark, M., Berdyshev, E. V., Gu, Y., Smith, P., Schweitzer, K. S., Pilewsky, J., et al. (2009) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2008-0264oc · Cited by 48 · cited 1×
“need for CF transmembrane regulator for stress-induced apoptosis in lung endothelial cells by maintaining adequate intracellular acidification and ceramide activation (30).”
Reduced endothelium-dependent relaxation of cystic fibrosis pulmonary arteries
Dinh‐Xuan, A. T., Higenbottam, T., Pepke-Zaba, J., Clelland, C., & Wallwork, J. L. (1989) · European Journal of Pharmacology · doi:10.1016/0014-2999(89)90217-3 · Cited by 48 · cited 1×
“Limited research exists in these cell types in CF with the only human studies reporting reduced endothelium-dependent relaxation of CF pulmonary arteries (29) and the”
García‐Álvarez, A., Fernández‐Friera, L., García‐Ruiz, J. M., Nuño-Ayala, M., Pereda, D., Fernández‐Jiménez, R., Guzmán, G., Sánchez‐Quintana, D., Alberich‐Bayarri, Á., Pastor-Escuredo, D., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.07.037 · Cited by 45
Endothelial Perturbation in Cystic Fibrosis
Romano, M., Collura, M., Iapichino, L., Pardo, F., Falco, A., Chiesa, P. L., Caimi, G., & Davì, G. (2001) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1616736 · Cited by 36
Hayes, D., Higgins, R. S., Kirkby, S., McCoy, K. S., Wehr, A. M., Lehman, A. M., & Whitson, B. A. (2014) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2013.12.004 · Cited by 35 · cited 1×
“Importantly, the presence and severity of PH does not alter outcomes after LTx as reported in a study of 831 CF patients from the UNOS/OPTN thoracic database (7).”
Self-citationMcKone, E. F., Barry, S. C., FitzGerald, M. X., & Gallagher, C. G. (2005) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00475.2004 · Cited by 30 · cited 1×
“space used to overcome the suppressive effects of hyperoxia on minute ventilation (27).”
Panidis, I. P., Ren, J., Holsclaw, D. S., Kotler, M. N., Mintz, G. S., & Ross, J. (1985) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(85)80134-0 · Cited by 29
Rovedder, P. M. E., Ziegler, B., Pinotti, A. F. F., Barreto, S. S. M., & Dalcin, P. D. T. R. (2008) · Jornal Brasileiro de Pneumologia · doi:10.1590/s1806-37132008000200004 · Cited by 28
Pulmonary hypertension is a mild comorbidity in end-stage cystic fibrosis patients
Meerkerk, G. B., Cramer, M. J., Erp, J. M. K., Nugroho, M. A., Tahri, S., de Valk, H. W., & van de Graaf, E. A. (2013) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2013.03.006 · Cited by 28
Manika, Κ., Pitsiou, G., Boutou, A., Tsaoussis, V., Chavouzis, N., Antoniou, M., Fotoulaki, M., Stanopoulos, I., & Kioumis, I. P. (2012) · Pulmonary Medicine · doi:10.1155/2012/252345 · Cited by 27
Ventricular Interdependence in Severe Cystic Fibrosis
Jacobstein, M. D., Hirschfeld, S. S., Winnie, G. B., Doershuk, C. F., & Liebman, J. (1981) · CHEST Journal · doi:10.1378/chest.80.4.399 · Cited by 27
Hypoxic pulmonary vasoconstriction
Evans, A. M. (2007) · Essays in Biochemistry · doi:10.1042/bse0430061 · Cited by 21
Bright-Thomas, R. J., Ray, S. G., & Webb, A. K. (2012) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2012.04.012 · Cited by 18
Rovedder, P. M. E., Ziegler, B., Pasin, L. R., Rampon, G., Pinotti, A. F. F., Dalcin, P. D. T. R., & Menna‐Barreto, S. S. (2006) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2006.10.009 · Cited by 17
Pulmonary Acceleration Time to Optimize the Timing of Lung Transplant in Cystic Fibrosis
Damy, T., Burgel, P., Pépin, J., Boëlle, P., Cracowski, C., Murris‐Espin, M., NOVE-JOSSERAND, R., Stremler, N., Simon, T., Adnot, S., et al. (2012) · Pulmonary Circulation · doi:10.4103/2045-8932.94838 · Cited by 15
Right heart catheterization measuring central hemodynamics in cystic fibrosis during exercise
Hayes, D., Daniels, C. J., Mansour, H. M., Kopp, B. T., Yates, A. R., McCoy, K., Patel, A. V., & Kirkby, S. E. (2013) · Respiratory Medicine · doi:10.1016/j.rmed.2013.02.020 · Cited by 9 · cited 1×
“Until the time for referral for LTx, transthoracic echocardiography is commonly used as a surrogate to assess right ventricular function and look for PH in CF, but it is limited (6, 10).”
Self-citationHayes, D., Daniels, C. J., Kirkby, S. E., Kopp, B. T., Nicholson, K. L., Nance, A. E., & Splaingard, M. (2014) · Lung · doi:10.1007/s00408-014-9573-x · Cited by 7 · cited 1×
“The pathophysiology of PH in lung disease in general, including CF, involves alveolar hypoxemia (26), acidosis (26), and hypercapnia (3) playing important roles.”
Self-citation
Research works printed but not linked: 2
- Venuta, 2012, Pulmonary hypertension is associated with higher mortality in cystic fibrosis patients awaiting lung transplantation, J Cardiovasc Surg (Torino), 53, 817
- Rovedder, 2008, Prevalence of pulmonary hypertension evaluated by Doppler echocardiography in a population of adolescent and adult patients with cystic fibrosis, J Bras Pneumol, 34, 83
Cited by
Leard, L. E., Holm, A. M., Valapour, M., Glanville, A. R., Attawar, S., Aversa, M., Campos, S. V., Christon, L. M., Cypel, M., Dellgren, G., et al. (2021) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2021.07.005 · Cited by 821
Ramos, K. J., Smith, P. J., McKone, E. F., Pilewski, J. M., Lucy, A., Hempstead, S. E., Tallarico, E., Faro, A., Rosenbluth, D. B., Gray, A. L., et al. (2019) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2019.03.002 · Cited by 227
Kapnadak, S. G., Dimango, E., Hadjiliadis, D., Hempstead, S. E., Tallarico, E., Pilewski, J. M., Faro, A., Albright, J., Benden, C., Blair, S., et al. (2020) · Journal of Cystic Fibrosis · doi:10.1016/j.jcf.2020.02.015 · Cited by 157
“Although the exact incidence is unknown due to varying definitions, pulmonary hypertension is also associated with increased mortality in ACFLD [39-41] .”
BackgroundPulmonary hypertension associated with lung diseases
Shlobin, O. A., Adir, Y., Barberà, J. A., Cottin, V., Harari, S. A., Jutant, E., Pepke‐Żaba, J., Ghofrani, H. A., & Channick, R. N. (2024) · European Respiratory Journal · doi:10.1183/13993003.01200-2024 · Cited by 179
“Furthermore, the presence of severe PH is associated with increased risk of waitlist mortality in patients listed for lung transplantation [197, 198].”
CFTR and sphingolipids mediate hypoxic pulmonary vasoconstriction
Tabeling, C., Yu, H., Wang, L., Ranke, H., Goldenberg, N. M., Zabini, D., Noe, E., Krauszman, A., Gutbier, B., Yin, J., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1421190112 · Cited by 93
“It is noteworthy, however, that the proposed mechanistic role of CFTR for PH is not unequivocally evident in CF patients, which have a similar prevalence of mild or moderate PH as patients with COPD and a comparable reduction in forced expiratory volume (FEV1) (42, 43).”
Background
Metadata
- Authors
- Hayes, D., Tobias, J. D., Mansour, H. M., Kirkby, S., McCoy, K. S., Daniels, C. J., & Whitson, B. A.
- Affiliations
- Department of Pediatrics
- The Ohio State University (US)
- University of Arizona (US)
- Nationwide Children's Hospital (US)
- Corresponding author
- Hayes, Don
- ORCID
- Venue
- American Journal of Respiratory and Critical Care Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2014-10-01
- Volume
- 190
- Issue
- 8
- Pages
- 898-905
- ISSN
- 1073-449X (ISSN-L)
- 1535-4970
- OpenAlex
- W1984445334
- Cited by
- 77
- References
- 38
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 4 · 2023: 4 · 2022: 3 · 2021: 9 · 2020: 8 · 2019: 9 · 2018: 4 · 2017: 9 · 2016: 7 · 2015: 14
- FWCI
- 8.01
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- American Journal of Respiratory and Critical Care Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Pulmonary Hypertension Research and Treatments
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Cystic Fibrosis Research Advances
- Health Sciences › Medicine › Surgery › Transplantation: Methods and Outcomes
- Keywords
- pulmonary hypertension, cystic fibrosis, advanced lung disease, survival, mortality risk, lung transplant candidates, right heart catheterization, mean pulmonary artery pressure, transplant waiting list
- MeSH terms
- Adolescent, Adult, Cystic Fibrosis, Female, Humans, Hypertension, Pulmonary, Male, Retrospective Studies, Risk Factors, Severity of Illness Index, United States, Survival Rate, Multivariate Analysis, Proportional Hazards Models, Lung Transplantation, Databases, Factual, Kaplan-Meier Estimate, Young Adult, Propensity Score
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.